Rising Cancer Prevalence Propels Growth In The Precision Medicine Market Is Supporting Development Across The Precision Medicine Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Precision Medicine Market In 2026 And 2030?

The precision medicine market has experienced robust growth in recent years. It is projected to expand from $87.91 billion in 2025 to $96.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. This historical expansion is primarily due to advancements in genomic research, the declining cost of gene sequencing, an increasing prevalence of cancer and genetic disorders, growth in biopharmaceutical R&D spending, and regulatory approvals for targeted therapies.

The precision medicine market is projected to experience substantial growth in the upcoming years, with its size anticipated to reach $137.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This expansion during the forecast period can be attributed to factors such as the increased adoption of next-generation sequencing, a rising demand for personalized treatment plans, the growing utilization of AI-driven drug discovery, an uptick in investments in precision diagnostics, and the integration of digital health platforms. Prominent trends for the forecast period include the increasing adoption of companion diagnostics, a shift towards personalized oncology therapies, the integration of multi-omics data in clinical decision-making, the broadening application of precision medicine in rare and genetic diseases, and enhanced collaboration between pharmaceutical and diagnostic firms.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp

What Primary Factors Are Fueling The Expansion Of The Precision Medicine Market?

The increasing incidence of cancer is anticipated to boost the expansion of the precision medicine market. Globally, cancer stands as a significant cause of mortality, with approximately one in five people experiencing a cancer diagnosis during their lifetime. Within oncology, precision medicine involves examining tumor DNA to identify mutations or other genetic irregularities responsible for cancer development. This approach allows physicians to select treatments tailored to a specific patient’s cancer, effectively targeting the identified tumor DNA alterations. For example, data released in February 2024 by the World Health Organization, a Switzerland-based specialized agency focusing on global public health, forecasts more than 35 million new cancer cases by 2050. This represents a substantial 77% surge from the approximately 20 million cases recorded in 2022. Consequently, the growing occurrence of cancer acts as a key driver for the expansion of the precision medicine market.

Which Segment Groups Define The Precision Medicine Market Landscape?

The precision medicine market covered in this report is segmented –

1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology

2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.

3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others

Subsegments:

1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining

2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis

3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing

4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials

5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests

6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology

What Trends Are Influencing The Future Of The Precision Medicine Market?

Key companies within the precision medicine sector are emphasizing innovation, particularly in data ingestion, which allows for easier access to public datasets via Google Cloud’s Analytics Hub. Data ingestion involves gathering and transferring information from various sources into a storage system or a data processing platform. For example, in May 2023, Google Cloud, a US-based software development company, unveiled two cutting-edge AI-driven solutions intended to boost drug discovery and precision medicine. These contemporary AI solutions are aiding in the acceleration of drug discovery and precision medicine for the biotechnology and pharmaceutical industries. Researchers can now more effectively identify protein structures and interpret genomic data, which enhances drug development processes. These instruments lessen the time it takes for life-saving treatments to reach the market and foster improved collaboration among research teams. They also offer support for multi-cloud setups, ensuring smooth integration.

Who Are The Leading Firms Participating In The Precision Medicine Market?

Major companies operating in the precision medicine market are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co.Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica

Access The Complete Precision Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Which Region Leads The Precision Medicine Market By Size?

North America was the largest region in the precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Precision Medicine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp

Browse Through More Reports Similar to the Global Precision Medicine Market 2026, By The Business Research Company

Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Artificial Intelligence Ai In Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

Precision Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795